Clinical Trial Update: A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis

View source ↗

Summary

Clinical trial update on a short-course pretomanid-containing regimen for rifampicin-resistant/multidrug-resistant pulmonary tuberculosis in patients with type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Pulmonary Tuberculosis
• Rifampicin-resistant Tuberculosis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Pretomanid (pretomanid)

Snippet

Sponsor: Wuhan Pulmonary Hospital | Conditions: Rifampicin-resistant/Multidrug-resistant Pulmonary Tuberculosis, Type 2 Diabetes Mellitus (T2DM) | Status: NOT_YET_RECRUITING